# Mereo BioPharma

> Developing transformative therapies for rare diseases

Business model and tags: Pharma & life sciences, Has in-house R&D

## About Mereo BioPharma

An agile biopharmaceutical company focusing on therapies for rare diseases, collaborating with stakeholders to bring new therapeutic possibilities to market

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 11–50 employees
- **Headquarters**: London, England, United Kingdom
- **Founded**: 2015
- **Revenue**: $500K (FY2025, publicly reported)
- **Website**: [mereobiopharma.com](https://www.mereobiopharma.com/)
- **LinkedIn**: [linkedin.com/company/mereo-biopharma](https://www.linkedin.com/company/mereo-biopharma)

## Mereo BioPharma at a glance

Mereo BioPharma is a company in the Biotechnology Research industry, headquartered in London, England, United Kingdom.

Mereo BioPharma was founded in 2015.

Mereo BioPharma has 11–50 employees.

Mereo BioPharma's revenue is $500K (FY2025, publicly reported).

## Frequently asked questions about Mereo BioPharma

### What is Mereo BioPharma's revenue?

Mereo BioPharma's revenue is $500K (FY2025, publicly reported).

### How many employees does Mereo BioPharma have?

Mereo BioPharma has 11–50 employees.

### Where is Mereo BioPharma headquartered?

Mereo BioPharma is headquartered in London, England, United Kingdom.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/mereo-biopharma